Stephen Simpson
Stephen Simpson
Stop FollowingStephen Simpson
View as an RSS Feed
COMMENTS STATS
401 Comments
393 Likes
Stephen Simpson
Stop FollowingStephen Simpson
Dentsply: A Great Stock, But Not A Great Price [View article]
BUT, that was some time ago and that perspective may not be relevant today.
Feeling A Little Better About The Growth/Value Proposition At Medtronic [View article]
Summer Infant Creating A Summer Of Discontent [View article]
MAKO Surgical Hooked, But Not Gutted [View article]
The two largest surgical robotics platforms (ISRG's da Vinci and MAKO's RIO) were approved via the 510(k) pathway and no clinical trials were required. That means less than a year for Stryker assuming no surprises or concerns with the FDA. Frankly, they could have already submitted their 510(k) application and none of us would know.
While ISRG has had to run clinical trials for subsequent tools, they've still been approved via the 510(k) process . It's unlikely that Stryker will be seeking broad multi-function labeling from the get-go, so the initial approval process will be straightforward.
Moreover, your closing statement has been proven wrong over and over again.
MAKO Surgical Hooked, But Not Gutted [View article]
The bigger issue would be price.
Also, keep in mind that MAKO's system is best for certain particular procedures/pt types and that's going to limit its usefulness in the scenario you laid out.
Patriot Coal: Different Coal Company, Same Coal Situation [View article]
If you're going to correct me, correct what I actually said.
I said "About 60-70% of the company's met coal goes to Europe,".
That is the percentage for Patriot. I never said 60-70% of industry-wide met coal goes to Europe, which is what you seem to be assuming.
Can Teva Win With The Big Pharma Playbook? [View article]
Disney Winning The Rat Race [View article]
Can Teva Win With The Big Pharma Playbook? [View article]
Can Teva Win With The Big Pharma Playbook? [View article]
MAKO Surgical Hooked, But Not Gutted [View article]
I'm highly confident that they can develop and launch a competitive system for less than $1.2B.
MAKO Surgical Hooked, But Not Gutted [View article]
1) Hospitals/docs "over-implanted" for years and essentially over-fished the reservoir.
2) The DOJ investigations/settlem... have significantly changed the marketing process and the patient selection process. It has also made hospitals more conservative about how they approach procedures.
3) As the avg age of TKR/THR recipients has skewed lower, it has started to be more economically sensitive; in the current economy people aren't as comfortable with the copays and/or taking off work for the rehab.
MAKO Surgical Hooked, But Not Gutted [View article]
Hope Springs Eternal At Ingersoll-Rand - But Should It? [View article]
MAKO Surgical Hooked, But Not Gutted [View article]